(株)ミズホメディーの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4595/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/08/30 | 日証協 | 420,907株 | +0.27% | 103,812株 | +96.93% | 309,076株 | -0.23% | 5,900株 | -45.37% |
2019/08/23 | 日証協 | 419,784株 | -1.26% | 52,716株 | +5.54% | 309,776株 | -0.77% | 10,800株 | -25.52% |
2019/08/16 | 日証協 | 425,149株 | -0.61% | 49,949株 | -1.65% | 312,176株 | -3.25% | 14,500株 | +62.92% |
2019/08/09 | 日証協 | 427,749株 | -1% | 50,787株 | +25.09% | 322,676株 | -2.15% | 8,900株 | -54.36% |
2019/08/02 | 日証協 | 432,060株 | -1.44% | 40,600株 | +46.57% | 329,776株 | -2.25% | 19,500株 | -28.31% |
2019/07/26 | 日証協 | 438,360株 | -3.5% | 27,700株 | +19.91% | 337,376株 | -2.85% | 27,200株 | +24.2% |
2019/07/19 | 日証協 | 454,272株 | +1.56% | 23,100株 | -65.18% | 347,276株 | +2.87% | 21,900株 | -27.96% |
2019/07/12 | 日証協 | 447,300株 | +4.9% | 66,340株 | -51.68% | 337,576株 | +2.4% | 30,400株 | -55.62% |
2019/07/05 | 日証協 | 426,407株 | +18.98% | 137,298株 | +32.92% | 329,676株 | +8.74% | 68,500株 | +62.71% |
2019/06/28 | 日証協 | 358,400株 | +17.01% | 103,297株 | +1.95% | 303,176株 | +4.34% | 42,100株 | +45.67% |
2019/06/21 | 日証協 | 306,300株 | -6.1% | 101,321株 | -2.29% | 290,576株 | -7.31% | 28,900株 | -16.47% |
2019/06/14 | 日証協 | 326,200株 | +8.84% | 103,700株 | +53.4% | 313,476株 | +7.69% | 34,600株 | +214.37% |
2019/06/07 | 日証協 | 299,700株 | +2.1% | 67,600株 | +82.98% | 291,082株 | +1.86% | 11,006株 | -73.75% |
2019/05/31 | 日証協 | 293,550株 | -12.78% | 36,944株 | -43.05% | 285,776株 | -1.58% | 41,920株 | +10.95% |
2019/05/24 | 日証協 | 336,553株 | -8.59% | 64,870株 | -78.46% | 290,352株 | -1.65% | 37,782株 | -72.07% |
2019/05/17 | 日証協 | 368,160株 | +193.82% | 301,110株 | +358.95% | 295,226株 | +63.76% | 135,251株 | +179.33% |
2019/05/10 | 日証協 | 125,300株 | +35.46% | 65,609株 | +122.45% | 180,276株 | +17% | 48,419株 | +256.02% |
2019/04/26 | 日証協 | 92,500株 | +31.77% | 29,494株 | +211.25% | 154,076株 | +11.91% | 13,600株 | -12.82% |
2019/04/19 | 日証協 | 70,200株 | -66.14% | 9,476株 | -20.6% | 137,676株 | -36.69% | 15,600株 | +119.41% |
※株式分割は考慮していませんのでご注意ください。
Page Top